on this page
Read the Guidelines for the continued dispensing of eligible prescribed medicines by pharmacists on the Pharmaceutical Society of Australia website.
Under this initiative:
- eligible pharmacists can supply certain Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) medicines without a prescription
- a patient can only get one supply per eligible medicine every 12 months.
This complements emergency supply provisions, including urgent communicated prescriptions under the PBS and state or territory legislation.
Medicines supplied under Continued Dispensing are subject to:
- PBS patient contributions and refund requirements
- section 51 of the National Health (Pharmaceutical Benefits) Regulations 2017 - immediate supply 20 day and 4 day rule.
The medicine also counts toward the patient's PBS Safety Net threshold.
Eligibility
Under Continued Dispensing, pharmacists must meet the requirements in the table below along with state or territory legislation:
Category | Description |
---|---|
Supplier | Only community pharmacies, under section 90 and section 90A approved suppliers can supply PBS medicines under Continued Dispensing. |
Patient |
The pharmacist must confirm the patient is either:
|
Medicine | Eligible medicines, including brands, are in the National Health (Continued Dispensing) Determination 2022 on the Federal Register of Legislation website. |
The Continued Dispensing initiative doesn’t cover repeat authorisations.
When Continued Dispensing is appropriate
Before a patient can get medicine under Continued Dispensing, make sure:
- the medicine is eligible for supply under Continued Dispensing
- the medicine was supplied to the patient in the last 3 months and their condition is stable
- the medicine is safe and appropriate for the patient
- a pharmacy hasn’t supplied the medicine in the past 12 months as a Continued Dispensing medicine
- there’s an immediate need for the medicine and circumstances prevented the patient from getting a prescription
- it’s not practical to obtain an e-prescription, owing prescription or communicated supply from the patient's usual prescriber.
You’ll need to record the information used to support your decision to supply medicine under Continued Dispensing. You must:
- keep records for 2 years from the date of supply
- keep your records consistent with other records
- comply with state or territory and Commonwealth legislation.
Dispensing details
When dispensing, use pharmacy dispensing software (PDS) to record:
- the medicine you supplied under Continued Dispensing. This will vary depending on your PDS
- the Australian Health Practitioner Regulation Agency (AHPRA) registration number of the pharmacist who supplied the medicine.
Online claiming for PBS
You must use online claiming for PBS for Continued Dispensing.
Your PDS will generate 2 forms:
Form 1 - Modified repeat authorisation form
Use this form to record:
- the details of the Continued Dispensing supply
- the patient’s, or their agent’s, signature to show they received the medicine.
Form 2 - Consumer declaration and prescriber notification form
Use this form to:
- show that the patient, or their agent, understands they were supplied without consultation from their prescriber
- notify the patient's prescriber that a Continued Dispensing supply was given
- notify the most recent prescriber, or their practice, in writing within 24 hours that the medicine was supplied.
You shouldn’t rely on online claiming for PBS for clinical decision making purposes.
Completing the forms
If the patient or their agent can’t sign, the pharmacist can certify supply on:
- the Modified repeat authorisation form
- the Consumer declaration and prescriber notification form.
Keep a copy of all completed and signed forms for 2 years from the date of supply.
More information
Read more about:
- the PBS on the Department of Health and Aged Care website
- education services for health professionals
- our website disclaimer.
Contact us about PBS general enquiries.
To give feedback on our education resources, contact us.